Investment adviser · CRD 173031

ADVENT LIFE SCIENCES LLP

Exempt reporting adviser (ERA)

Exempt reporting advisers use a shorter Form ADV report. Some adviser-level figures are not reported; fund disclosures appear below when available.

LONDON, United Kingdom · Form ADV filed Mar 26, 2026

Adviser-level assets, account counts and staffing figures are unavailable in this filing. View the reported fund disclosures below →

Private funds & service providers

7 Private funds

The count excludes feeder funds. Funds in the latest filing appear first, ordered by reported gross assets. Earlier funds retain their last reported values.

ADVENT LIFE SCIENCES FUND I LPVenture Capital Fund · Last reported Mar 26, 2026$247MGross asset value
Auditor KPMG LONDON, United Kingdom
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No

KPMG
PCAOB 1119

Fund details & source
Fund ID
805-6391670466
Reported beneficial owners
13
Minimum commitment
$1.5M

Form ADV 2072193 · Mar 26, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

ADVENT LIFE SCIENCES GROWTH FUND LPVenture Capital Fund · Last reported Mar 26, 2026$171MGross asset value
Fund administrator AZTEC GROUP LONDON, United Kingdom Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG LONDON, United Kingdom
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
Yes
External marketing
No

KPMG
PCAOB 1119

Fund details & source
Fund ID
805-9748011033
Reported beneficial owners
8
Minimum commitment
$4.5M

Form ADV 2072193 · Mar 26, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

ADVENT LIFE SCIENCES FUND II LPVenture Capital Fund · Last reported Mar 26, 2026$159MGross asset value

Form D fundraising filings

Advent Life Sciences Fund II LP

Auditor KPMG LONDON, United Kingdom
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No

KPMG
PCAOB 1119

Fund details & source
Fund ID
805-3053351816
Reported beneficial owners
15
Minimum commitment
$4.5M
Form D file number
021-224448

Form ADV 2072193 · Mar 26, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

ADVENT LIFE SCIENCES FUND III LPVenture Capital Fund · Last reported Mar 26, 2026$154MGross asset value

Form D fundraising filings

Advent Life Sciences Fund III LP

Fund administrator AZTEC GROUP LONDON, United Kingdom Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG LONDON, United Kingdom
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
Yes
External marketing
No

KPMG
PCAOB 1119

Fund details & source
Fund ID
805-2883803215
Reported beneficial owners
10
Minimum commitment
$4.5M
Form D file number
021-327448

Form ADV 2072193 · Mar 26, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

ADVENT-HARRINGTON IMPACT FUND LPVenture Capital Fund · Last reported Mar 26, 2026$52.2MGross asset value

Form D fundraising filings

Advent-Harrington Impact Fund LP

Fund administrator AZTEC GROUP LONDON, United Kingdom Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG LONDON, United Kingdom
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
Yes
External marketing
No

KPMG
PCAOB 1119

Fund details & source
Fund ID
805-3761935108
Reported beneficial owners
60
Minimum commitment
$250K
Form D file number
021-380008

Form ADV 2072193 · Mar 26, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

BIOMOTIV LLCVenture Capital Fund · Last reported Mar 26, 2026$27.9MGross asset value

Form D fundraising filings

BioMotiv, LLC

Auditor EISNER AMPER NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No

EISNER AMPER
PCAOB 274

Fund details & source
Fund ID
805-6862260237
Reported beneficial owners
84
Minimum commitment
$250K
Form D file number
021-183660

Form ADV 2072193 · Mar 26, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

ADVENT LIFE SCIENCES II CO-INVEST LPVenture Capital Fund · Last reported Mar 26, 2026$18.6MGross asset value
Auditor KPMG LONDON, United Kingdom
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No

KPMG
PCAOB 1119

Fund details & source
Fund ID
805-4202756838
Reported beneficial owners
2
Minimum commitment
$2.6M

Form ADV 2072193 · Mar 26, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Services & filing details

Most recent filing: Mar 26, 2026. View historical filings

Reported services

Not reported in these imported fields

Compensation

Not reported in these imported fields

Principal office

27 FITZROY SQUARE
LONDON, W1T 6ES, United Kingdom

CRD 173031

Filing source

Form ADV 2072193 · Mar 26, 2026 · Items 1 & 5

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.